Status:
COMPLETED
A Research Study for Patients With Overactive Bladder
Lead Sponsor:
Allergan
Conditions:
Overactive Bladder
Urinary Incontinence
Eligibility:
All Genders
18-85 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to investigate whether injections of botulinum toxin Type A into the bladder are safe and effective in treating overactive bladder.
Eligibility Criteria
Inclusion
- Must be between 18-85 years old
- Must have been diagnosed by his/her doctor with overactive bladder at least 6 months ago
- Must weigh at least 50 kg (110 lbs)
- Must be willing and able to record information regarding bladder function into a diary (provided)
- Must be willing and able to complete the entire course of the study
Exclusion
- Cannot currently be catheterizing as a way to control incontinence
- Must not have used botulinum toxin type A or any other botulinum toxin previously for any condition
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2008
Estimated Enrollment :
313 Patients enrolled
Trial Details
Trial ID
NCT00168454
Start Date
July 1 2005
End Date
June 1 2008
Last Update
November 6 2013
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Pittsburgh, Pennsylvania, United States
2
Ghent, Belgium
3
Victoria, British Columbia, Canada
4
Berlin, Germany